Enzyme immunoassays were developed for the detection of Breda virus antibody and antigen. Cattle sera collected in the United Kingdom were found to have a high prevalence of antibody (55%) to Breda virus when examined in a competitive enzyme-linked immunosorbent assay. A low prevalence of antibody was found in pigs (2.2%), and no antibody was found in sheep or goat sera. No antibody to either Breda virus or Berne virus was detected in human sera collected from veterinarians and farm workers. Only 1 of 430 human fecal specimens (0.2%) contained Breda virus antigen detectable by enzyme-linked immunosorbent assay.
Enzyme immunoassays were developed for the detection of Breda virus antibody and antigen. Cattle sera collected in the United Kingdom were found to have a high prevalence of antibody (55%) to Breda virus when examined in a competitive enzyme-linked immunosorbent assay. A low prevalence of antibody was found in pigs (2.2%), and no antibody was found in sheep or goat sera. No antibody to either Breda virus or Berne virus was detected in human sera collected from veterinarians and farm workers. Only 1 of 430 human fecal specimens (0.2%) contained Breda virus antigen detectable by enzyme-linked immunosorbent assay.
Breda virus was first isolated from diarrheic calves in the United States in 1982 (9) . It was shown to be infectious by mouth, causing diarrhea in gnotobiotic and conventionally reared calves. Two serogroups of Breda virus have been proposed, although they have yet to be grown in tissue culture (10) . Breda virus is antigenically and morphologically related to Berne virus, which was isolated from a rectal swab taken from a horse in Switzerland in 1973 and which can be grown in tissue culture (6) . In 1984, Horzinek et al. proposed that Berne virus should be the type strain of a new family of viruses called the Toroviridae, which are characterized by their unique morphology by electron microscopy (EM), polypeptide profile on sodium dodecyl sulfate-acrylamide gels, and genome organization (4, 5) .
We have reported previously the existence of Breda viruslike particles in stool samples from children (1, 2). We were able to show morphological similarities to Breda virus and a serological cross-reaction by immune EM with a hyperimmune serum raised against Breda Il. However, since direct EM has not proved to be a sensitive technique for the detection of these viruses in humans, we have developed an enzyme-linked immunosorbent assay (ELISA) for Breda virus antigen by using sera raised against Breda Il virus to look for further evidence of torovirus infection in humans.
Antibodies to toroviruses are widespread in animals. A high prevalence of neutralizing antibody to Berne virus has been found in cattle and horses, and a much lower prevalence has been found in rabbits and rodents (7) . A high prevalence of antibody to Breda virus has been found in cattle in the United States by hemagglutination (HA) inhibition (HAI) (9) and indirect ELISA (8, 10 pended in and dialyzed against 0.01 M Tris hydrochloride, pH 7.2, with 0.001 M EDTA and 0.15 M NaCl (TES buffer) for 18 h. The virus was further purified by centrifugation at 100,000 x g for 2 h through a preformed linear sucrose gradient consisting of 15 to 60% (wt/wt) solutions of sucrose in TES. The peak fractions by ELISA were pooled, dialyzed as before against TES, and diluted in phosphate-buffered saline (PBS), pH 7.2, containing 0.2% Tween 20 (PBST) with 1% bovine serum albumin for use in the competitive ELISA. Antisera. A hyperimmune antiserum (GC76) to Breda Il virus was provided by G. Woode. It was produced by intramuscular inoculation of a previously infected gnotobiotic calf with Breda II virus purified from the feces of the calf (9) . The hyperimmune guinea pig serum (Gp475) was produced in this laboratory by intramuscular inoculation with the virus-containing gradient fractions from the purification procedure described above. The peak fractions were mixed with an equal volume of Freund incomplete adjuvant. Two inoculations were given 1 month apart. The calf immunoglobulin was purified by precipitation in 40% ammonium sulfate and biotinylated for use in the ELISA by a method previously described (11) .
HAI tests. HA and HAI tests were performed as previously described (1) . Berne Human fecal specimens. A total of 400 10% fecal extracts were examined. These were routine specimens received at the Regional Virus Laboratory for the investigation of diarrhea between January and April 1986. Most of these samples were from children younger than 5 years. Thirty human fecal specimens were sent to the Regional Virus Laboratory because they contained toroviruslike particles on examination by EM.
Sera examined. The specificity of this ELISA for Breda virus-specific antibody was assessed by examining well-RESULTS Specificity and sensitivity of ELISA for antigen detection. The specificity and sensitivity of the ELISA for antigen detection were assessed by examining Breda I and Breda Il virus preparations in the assay and by comparing the sensitivity of the ELISA with that of HA. The results are shown in Fig. 1 The specificity of the assay was assessed by examining fractions from a sucrose density purification of Breda II virus preparation. The results are shown in Fig. 2 . In the isopycnic sucrose gradient centrifugation of GC62, a gnotobiotic calf fecal preparation, a single peak of ELISA activity was detected in fractions with a density of 1.14 g/ml. This corresponded to the peak virus fractions by EM and HA. Figure 3 shows the result of an isopycnic sucrose gradient centrifugation of GC46, a gnotobiotic calf fecal preparation. Peaks of ELISA activity were detected in the fractions with densities of 1.16 and 1.07 g/ml. Virus particles without peplomers were detected by EM in the denser peak; no particles were seen in the 1.07-g/ml peak. In Investigation of human fecal samples. We looked for evidence of Breda-like viruses in humans. Specimens of feces (n = 400) were examined, and 15 gave reactions of >0.1 OD450 in the Breda virus antigen ELISA. These 15 specimens were investigated further by testing them in parallel in the antigen test by coating the plate with pre-and postimmune sera (Gp475). All 15 reacted equally in both tests, and none of these specimens contained any Breda virus-specific hemagglutinin. A further 30 human specimens, which contained toroviruslike particles by EM, were examined. One of these specimens (designated 1690) gave a positive reaction (>0.100 OD450) in the test. Fractions from a sucrose density gradient purification of this specimen were examined in the ELISA; the results are shown in Fig. 3 . A single peak of reactivity was detected in the fractions at a density of 1.14 g/ml; this peak contained hemagglutinin which was inhibited by serum from a convalescent calf infected with Breda Il virus (1).
Antibody prevalence. Sera (n = 209) from animal species were tested for evidence of Breda virus-specific antibody. The results are shown in Table 2 . A high prevalence of antibody was found in cattle (55%). All cattle sera giving inhibitions of >40% (42 of 51) were also tested by HAI, and all 42 had titers of >20. Of 45 pig sera examined, 1 gave an inhibition of >60% in the ELISA, and this serum had an HAI titer of 320 to Breda Il virus. Of 11 sheep sera, 1 gave >60% inhibition in the ELISA, but the serum had an HAI titer of <20. No antibody to Breda virus was detected in sera collected from goats. No Breda virus antibody or Berne virus-neutralizing antibody was detected in the 92 sera collected from veterinarians, veterinary students, and farm workers.
DISCUSSION
Previous studies have used either HA or EM to identify Breda-like viruses in clinical material (8, 9) . For human samples, the value of HA was limited by the widespread distribution of rat cell hemagglutinins in human feces (1) . Similarly, EM is of limited use because Breda viruses disintegrate rapidly on storage (9) . Thus, the ELISA for antigen detection should prove valuable as a diagnostic tool in the investigation of clinical material for both serotypes of Breda virus.
The specificity of this assay was confirmed for Breda viruses by testing fractions separated from Breda virus suspensions by centrifugation through a sucrose density gradient. The finding of ELISA activity in fractions at three different densities (1.14 g/ml [whole virus], 1.16 g/ml [whole It has been previously reported that sera from Swiss blood donors contained no Berne virus-neutralizing activity (7) . We extended this study by examining sera from veterinarians and farm workers as a possible "sentinel group" for evidence of a zoonotic torovirus infection. We also examined the same sera for antibodies to 
